{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T22:02:53Z","timestamp":1758405773793},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"DOI":"10.1007\/s00108-022-01351-7","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T14:15:08Z","timestamp":1652105708000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interventionelle Therapie der peripheren arteriellen Verschlusskrankheit"],"prefix":"10.1007","author":[{"given":"Sabine","family":"Steiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"issue":"Suppl 95","key":"1351_CR1","first-page":"1","volume":"45","author":"S3-Leitlinie PAVK","year":"2016","unstructured":"S3-Leitlinie PAVK (2016) Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit. Vasa 45(Suppl 95):1\u2013100","journal-title":"Vasa"},{"key":"1351_CR2","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans\u00a0V, Ricco\u00a0JB, Bartelink\u00a0MEL, Bjorck\u00a0M, Brodmann\u00a0M, Cohnert\u00a0T, Collet\u00a0JP et\u00a0al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart\u00a0J 39:763\u2013816","journal-title":"Eur Heart J"},{"key":"1351_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/1358863X15597877","volume":"20","author":"TS Committee","year":"2015","unstructured":"Committee\u00a0TS, Jaff\u00a0MR, White\u00a0CJ, Hiatt\u00a0WR, Fowkes\u00a0GR, Dormandy\u00a0J, Razavi\u00a0M et al (2015) An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). Vasc Med 20:465\u2013478","journal-title":"Vasc Med"},{"issue":"Suppl S","key":"1351_CR4","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren\u00a0L, Hiatt\u00a0WR, Dormandy\u00a0JA, Nehler\u00a0MR, Harris\u00a0KA, Fowkes\u00a0FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J\u00a0Vasc Surg 45(Suppl S):S5\u201367","journal-title":"J Vasc Surg"},{"key":"1351_CR5","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jvs.2010.04.080","volume":"52","author":"V Jongkind","year":"2010","unstructured":"Jongkind\u00a0V, Akkersdijk\u00a0GJ, Yeung\u00a0KK, Wisselink\u00a0W (2010) A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J\u00a0Vasc Surg 52:1376\u20131383","journal-title":"J Vasc Surg"},{"key":"1351_CR6","first-page":"14","volume":"59","author":"JA Bekken","year":"2018","unstructured":"Bekken\u00a0JA, Jongsma\u00a0H, Fioole\u00a0B (2018) The use of covered stents in aortoiliac obstructions: a\u00a0systematic review and meta-analysis. J\u00a0Cardiovasc Surg (Torino) 59:14\u201325","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"1351_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ccd.21104","volume":"69","author":"KJ Rocha-Singh","year":"2007","unstructured":"Rocha-Singh\u00a0KJ, Jaff\u00a0MR, Crabtree\u00a0TR, Bloch\u00a0DA, Ansel\u00a0G (2007) Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 69:910\u2013919","journal-title":"Catheter Cardiovasc Interv"},{"key":"1351_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","volume":"45","author":"D Scheinert","year":"2005","unstructured":"Scheinert\u00a0D, Scheinert\u00a0S, Sax\u00a0J, Piorkowski\u00a0C, Braunlich\u00a0S, Ulrich\u00a0M, Biamino\u00a0G et\u00a0al (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J\u00a0Am Coll Cardiol 45:312\u2013315","journal-title":"J Am Coll Cardiol"},{"key":"1351_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.semvascsurg.2021.10.009","volume":"34","author":"KM Sanders","year":"2021","unstructured":"Sanders\u00a0KM, Schneider\u00a0PA, Conte\u00a0MS, Iannuzzi\u00a0JC (2021) Endovascular treatment of high-risk peripheral vascular occlusive lesions: a\u00a0review of current evidence and emerging applications of intravascular lithotripsy, atherectomy, and paclitaxel-coated devices. Semin Vasc Surg 34:172\u2013187","journal-title":"Semin Vasc Surg"},{"key":"1351_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","volume":"14","author":"G Tepe","year":"2021","unstructured":"Tepe\u00a0G, Brodmann\u00a0M, Werner\u00a0M, Bachinsky\u00a0W, Holden\u00a0A, Zeller\u00a0T, Mangalmurti\u00a0S et al (2021) Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized disrupt PAD III trial. JACC Cardiovasc Interv 14:1352\u20131361","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"1351_CR11","doi-asserted-by":"publisher","first-page":"CD006680","DOI":"10.1002\/14651858.CD006680.pub3","volume":"9","author":"BG Wardle","year":"2020","unstructured":"Wardle\u00a0BG, Ambler\u00a0GK, Radwan\u00a0RW, Hinchliffe\u00a0RJ, Twine\u00a0CP (2020) Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev 9(9):CD006680. https:\/\/doi.org\/10.1002\/14651858.CD006680.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1351_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eclinm.2019.09.004","volume":"16","author":"C Klumb","year":"2019","unstructured":"Klumb\u00a0C, Lehmann\u00a0T, Aschenbach\u00a0R, Eckardt\u00a0N, Teichgraber\u00a0U (2019) Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine 16:42\u201350","journal-title":"EClinicalMedicine"},{"key":"1351_CR13","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","volume":"133","author":"MD Dake","year":"2016","unstructured":"Dake\u00a0MD, Ansel\u00a0GM, Jaff\u00a0MR, Ohki\u00a0T, Saxon\u00a0RR, Smouse\u00a0HB, Machan\u00a0LS et al (2016) Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5\u2011year results of the Zilver PTX randomized trial. Circulation 133:1472\u20131483 (discussion 1483)","journal-title":"Circulation"},{"key":"1351_CR14","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","volume":"7","author":"K Katsanos","year":"2018","unstructured":"Katsanos\u00a0K, Spiliopoulos\u00a0S, Kitrou\u00a0P, Krokidis\u00a0M, Karnabatidis\u00a0D (2018) Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J\u00a0Am Heart Assoc 7:e11245","journal-title":"J Am Heart Assoc"},{"key":"1351_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","volume":"4","author":"EA Secemsky","year":"2019","unstructured":"Secemsky\u00a0EA, Kundi\u00a0H, Weinberg\u00a0I, Jaff\u00a0MR, Krawisz\u00a0A, Parikh\u00a0SA, Beckman\u00a0JA et al (2019) Association of survival with femoropopliteal artery revascularization with drug-coated devices. JAMA Cardiol 4:332\u2013340","journal-title":"JAMA Cardiol"},{"key":"1351_CR16","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1093\/eurheartj\/ehz698","volume":"41","author":"E Freisinger","year":"2020","unstructured":"Freisinger\u00a0E, Koeppe\u00a0J, Gerss\u00a0J, Goerlich\u00a0D, Malyar\u00a0NM, Marschall\u00a0U, Faldum\u00a0A et al (2020) Mortality after use of paclitaxel-based devices in peripheral arteries: a\u00a0real-world safety analysis. Eur Heart\u00a0J 41:3732\u20133739","journal-title":"Eur Heart J"},{"key":"1351_CR17","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.jcin.2020.04.050","volume":"13","author":"T B\u00f6hme","year":"2020","unstructured":"B\u00f6hme\u00a0T, Noory\u00a0E, Beschorner\u00a0U, Jacques\u00a0B, B\u00fcrgelin\u00a0K, Macharzina\u00a0R, Gebauer\u00a0E et al (2020) Evaluation of mortality following paclitaxel drug-coated balloon angioplasty of femoropopliteal lesions in the real world. JACC Cardiovasc Interv 13:2052\u20132061","journal-title":"JACC Cardiovasc Interv"},{"key":"1351_CR18","doi-asserted-by":"publisher","first-page":"e008528","DOI":"10.1161\/CIRCINTERVENTIONS.119.008528","volume":"13","author":"DJ Bertges","year":"2020","unstructured":"Bertges\u00a0DJ, Sedrakyan\u00a0A, Sun\u00a0T, Eslami\u00a0MH, Schermerhorn\u00a0M, Goodney\u00a0PP, Beck\u00a0AW et\u00a0al (2020) Mortality after paclitaxel coated balloon angioplasty and stenting of superficial femoral and popliteal artery in the vascular quality initiative. Circ Cardiovasc Interv 13:e8528","journal-title":"Circ Cardiovasc Interv"},{"key":"1351_CR19","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","volume":"383","author":"J Nordanstig","year":"2020","unstructured":"Nordanstig\u00a0J, James\u00a0S, Andersson\u00a0M, Andersson\u00a0M, Danielsson\u00a0P, Gillgren\u00a0P, Delle\u00a0M et al (2020) Mortality with paclitaxel-coated devices in peripheral artery disease. N\u00a0Engl J Med 383:2538\u20132546","journal-title":"N Engl J Med"},{"key":"1351_CR20","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jacc.2021.08.052","volume":"78","author":"CN Hess","year":"2021","unstructured":"Hess\u00a0CN, Patel\u00a0MR, Bauersachs\u00a0RM, Anand\u00a0SS, Debus\u00a0ES, Nehler\u00a0MR, Fanelli\u00a0F et al (2021) Safety and effectiveness of paclitaxel drug-coated devices in peripheral artery revascularization: insights from VOYAGER PAD. J\u00a0Am Coll Cardiol 78:1768\u20131778","journal-title":"J Am Coll Cardiol"},{"key":"1351_CR21","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1161\/CIRCULATIONAHA.119.044697","volume":"141","author":"KJ Rocha-Singh","year":"2020","unstructured":"Rocha-Singh\u00a0KJ, Duval\u00a0S, Jaff\u00a0MR, Schneider\u00a0PA, Ansel\u00a0GM, Lyden\u00a0SP, Mullin\u00a0CM et al (2020) Mortality and paclitaxel-coated devices: an individual patient data meta-analysis. Circulation 141:1859\u20131869","journal-title":"Circulation"},{"key":"1351_CR22","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jcin.2017.03.046","volume":"10","author":"Y Goueffic","year":"2017","unstructured":"Goueffic\u00a0Y, Della Schiava\u00a0N, Thaveau\u00a0F, Rosset\u00a0E, Favre\u00a0JP, Salomon du Mont\u00a0L, Alsac\u00a0JM et\u00a0al (2017) Stenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv 10:1344\u20131354","journal-title":"JACC Cardiovasc Interv"},{"key":"1351_CR23","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/eurheartj\/eht288","volume":"34","author":"N Malyar","year":"2013","unstructured":"Malyar\u00a0N, Furstenberg\u00a0T, Wellmann\u00a0J, Meyborg\u00a0M, Luders\u00a0F, Gebauer\u00a0K, Bunzemeier\u00a0H et al (2013) Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a\u00a0nationwide population-based analysis. Eur Heart\u00a0J 34:2706\u20132714","journal-title":"Eur Heart J"},{"key":"1351_CR24","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.jcin.2019.06.048","volume":"12","author":"A Schmidt","year":"2019","unstructured":"Schmidt\u00a0A, Bausback\u00a0Y, Piorkowski\u00a0M, Wittig\u00a0T, Banning-Eichenseer\u00a0U, Thiele\u00a0H, Aldmour\u00a0S et al (2019) Retrograde tibioperoneal access for complex Infrainguinal occlusions: short- and long-term outcomes of 554 endovascular interventions. JACC Cardiovasc Interv 12:1714\u20131726","journal-title":"JACC Cardiovasc Interv"},{"key":"1351_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejvs.2011.11.025","volume":"43","author":"O Iida","year":"2012","unstructured":"Iida\u00a0O, Soga\u00a0Y, Hirano\u00a0K, Kawasaki\u00a0D, Suzuki\u00a0K, Miyashita\u00a0Y, Nanto\u00a0S et al (2012) Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischaemia due to isolated below-the-knee lesions. Eur J Vasc Endovasc Surg 43:313\u2013321","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1351_CR26","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jcin.2020.06.045","volume":"13","author":"F Liistro","year":"2020","unstructured":"Liistro\u00a0F, Angioli\u00a0P, Ventoruzzo\u00a0G, Ducci\u00a0K, Reccia\u00a0MR, Ricci\u00a0L, Falsini\u00a0G et al (2020) Randomized controlled trial of acotec drug-eluting balloon versus plain balloon for below-the-knee angioplasty. JACC Cardiovasc Interv 13:2277\u20132286","journal-title":"JACC Cardiovasc Interv"},{"key":"1351_CR27","first-page":"313","volume":"54","author":"RL Varcoe","year":"2013","unstructured":"Varcoe\u00a0RL (2013) Drug eluting stents in the treatment of below the knee arterial occlusive disease. J\u00a0Cardiovasc Surg (Torino) 54:313\u2013325","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"1351_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1526602820922179","volume":"27","author":"A Schmidt","year":"2020","unstructured":"Schmidt\u00a0A, Schreve\u00a0MA, Huizing\u00a0E, Del Giudice\u00a0C, Branzan\u00a0D, \u00dcnl\u00fc \u00c7, Varcoe\u00a0RL et al (2020) Midterm outcomes of percutaneous deep venous arterialization with a\u00a0dedicated system for patients with no-option chronic limb-threatening ischemia: the ALPS multicenter study. J\u00a0Endovasc Ther 27:658\u2013665","journal-title":"J Endovasc Ther"},{"key":"1351_CR29","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","volume":"42","author":"V Aboyans","year":"2021","unstructured":"Aboyans\u00a0V, Bauersachs\u00a0R, Mazzolai\u00a0L, Brodmann\u00a0M, Palomares\u00a0JFR, Debus\u00a0S, Collet\u00a0JP et\u00a0al (2021) Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a\u00a0consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. Eur Heart\u00a0J 42:4013\u20134024","journal-title":"Eur Heart J"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01351-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01351-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01351-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T14:15:13Z","timestamp":1652105713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01351-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":29,"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01351-7","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"28 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Steiner: Beratert\u00e4tigkeit f\u00fcr Bayer, Boston Scientific, Cook Medical. Forschungsunterst\u00fctzung: C.R. Bard. A.\u00a0Schmidt: Beratert\u00e4tigkeit\/Vortragshonorare: C.R. Bard, Cook, Cordis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}